This is a Validated Antibody Database (VAD) review about rat cystic fibrosis transmembrane conductance regulator, based on 10 published articles (read how Labome selects the articles), using cystic fibrosis transmembrane conductance regulator antibody in all methods. It is aimed to help Labome visitors find the most suited cystic fibrosis transmembrane conductance regulator antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
cystic fibrosis transmembrane conductance regulator synonym: RGD1561193; cystic fibrosis transmembrane conductance regulator; ATP-binding cassette sub-family C member 7; ATP-binding cassette transporter sub-family C member 7; cAMP-dependent chloride channel; channel conductance-controlling ATPase; cystic fibrosis transmembrane conductance regulator homolog
Knockout validation
Abcam mouse monoclonal (CF3) |
| Abcam cystic fibrosis transmembrane conductance regulator antibody (Abcam, ab2784) was used in western blot knockout validation on mouse samples at 1:1000 (fig 2). Cell Death Differ (2016) ncbi |
Abcam
mouse monoclonal (CF3) |
| Abcam cystic fibrosis transmembrane conductance regulator antibody (Abcam, 2784) was used in immunohistochemistry on human samples (fig 1b). Sci Rep (2018) ncbi |
mouse monoclonal (CF3) |
| Abcam cystic fibrosis transmembrane conductance regulator antibody (Abcam, CF3) was used in immunocytochemistry on human samples (fig 2i) and in immunohistochemistry - paraffin section on mouse samples (fig 5b). Nat Med (2017) ncbi |
mouse monoclonal (CF3) |
| Abcam cystic fibrosis transmembrane conductance regulator antibody (Abcam, ab2784) was used in western blot on human samples at 1:500 (fig 1b) and in western blot on mouse samples at 1:500 (fig 3b). Exp Physiol (2016) ncbi |
mouse monoclonal (CF3) |
| Abcam cystic fibrosis transmembrane conductance regulator antibody (Abcam, ab2784) was used in western blot knockout validation on mouse samples at 1:1000 (fig 2). Cell Death Differ (2016) ncbi |
mouse monoclonal (CF3) |
| Abcam cystic fibrosis transmembrane conductance regulator antibody (Abcam, ab2784) was used in western blot on human samples (fig s2). PLoS ONE (2016) ncbi |
mouse monoclonal (CF3) |
| Abcam cystic fibrosis transmembrane conductance regulator antibody (Abcam, CF3) was used in flow cytometry on human samples at 1:20 (fig 1b). Curr Cancer Drug Targets (2016) ncbi |
mouse monoclonal (CF3) |
| Abcam cystic fibrosis transmembrane conductance regulator antibody (Abcam, ab2784) was used in immunohistochemistry on human samples (fig 3). Exp Cell Res (2015) ncbi |
mouse monoclonal (CF3) |
| Abcam cystic fibrosis transmembrane conductance regulator antibody (Abcam, ab2784) was used in immunohistochemistry on pig samples at 1:50. Br J Pharmacol (2014) ncbi |
Alomone Labs
rabbit polyclonal |
| In order to analyze thermal inhalation injury and pulmonary inflammation and the role of CFTR-regulated MAPK/NF-kappa B signaling, Alomone Labs cystic fibrosis transmembrane conductance regulator antibody (Alomone labs, ACL-006) was used in western blot on human samples at 1:200 (fig 1). Sci Rep (2015) ncbi |
rabbit polyclonal |
| Alomone Labs cystic fibrosis transmembrane conductance regulator antibody (Alomone Labs, ACL-006) was used in immunohistochemistry - paraffin section on mouse samples at 1:1000, in western blot on mouse samples at 1:1200 and in immunohistochemistry - paraffin section on human samples at 1:1000. PLoS ONE (2014) ncbi |
Articles Reviewed
- Fanelli M, Hattinger C, Vella S, Tavanti E, Michelacci F, Gudeman B, et al. Targeting ABCB1 and ABCC1 with their Specific Inhibitor CBT-1® can Overcome Drug Resistance in Osteosarcoma. Curr Cancer Drug Targets. 2016;16:261-74 pubmed
- Zhou M, Fu J, Huang W, Shen L, Xiao L, Song Y, et al. Increased cystic fibrosis transmembrane conductance regulators expression and decreased epithelial sodium channel alpha subunits expression in early abortion: findings from a mouse model and clinical cases of abortion. PLoS ONE. 2014;9:e99521 pubmed publisher
contribute
- If you are aware of any publication with knockout studies validating a monoclonal or recombinant antibody, either purchased from a supplier or developed by the author(s), please notify us through feedback.
questions and comments